Literature DB >> 22628409

Gene signatures associated with mouse postnatal hindbrain neural stem cells and medulloblastoma cancer stem cells identify novel molecular mediators and predict human medulloblastoma molecular classification.

Daniela Corno1, Corno Daniela, Mauro Pala, Manuela Cominelli, Barbara Cipelletti, Ketty Leto, Laura Croci, Valeria Barili, Federico Brandalise, Raffaella Melzi, Alessandra Di Gregorio, Lucia Sergi Sergi, Letterio Salvatore Politi, Lorenzo Piemonti, Alessandro Bulfone, Paola Rossi, Ferdinando Rossi, Gian Giacomo Consalez, Pietro Luigi Poliani, Rossella Galli.   

Abstract

Medulloblastoma arises from mutations occurring in stem/progenitor cells located in restricted hindbrain territories. Here we report that the mouse postnatal ventricular zone lining the IV ventricle also harbors bona fide stem cells that, remarkably, share the same molecular profile with cerebellar white matter-derived neural stem cells (NSC). To identify novel molecular mediators involved in medulloblastomagenesis, we compared these distinct postnatal hindbrain-derived NSC populations, which are potentially tumor initiating, with murine compound Ptch/p53 mutant medulloblastoma cancer stem cells (CSC) that faithfully phenocopy the different variants of human medulloblastoma in vivo. Transcriptome analysis of both hindbrain NSCs and medulloblastoma CSCs resulted in the generation of well-defined gene signatures, each reminiscent of a specific human medulloblastoma molecular subclass. Most interestingly, medulloblastoma CSCs upregulated developmentally related genes, such as Ebfs, that were shown to be highly expressed in human medulloblastomas and play a pivotal role in experimental medullo-blastomagenesis. These data indicate that gene expression analysis of medulloblastoma CSCs holds great promise not only for understanding functional differences between distinct CSC populations but also for identifying meaningful signatures that might stratify medulloblastoma patients beyond histopathologic staging.

Entities:  

Mesh:

Year:  2012        PMID: 22628409     DOI: 10.1158/2159-8290.CD-11-0199

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  11 in total

1.  Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.

Authors:  J Rodriguez-Blanco; L Pednekar; C Penas; B Li; V Martin; J Long; E Lee; W A Weiss; C Rodriguez; N Mehrdad; D M Nguyen; N G Ayad; P Rai; A J Capobianco; D J Robbins
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

2.  Apples to origins: identifying brain tumor stem cell genes by comparing transcriptomes of normal and cancer stem cells.

Authors:  Matthew Wortham; Hai Yan
Journal:  Cancer Discov       Date:  2012-06       Impact factor: 39.397

3.  Isolation and Culture of Neural Stem/Progenitor Cells from the Postnatal Periventricular Region.

Authors:  Alessandra Ricca; Federica Cascino; Angela Gritti
Journal:  Methods Mol Biol       Date:  2022

4.  A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.

Authors:  Jezabel Rodriguez-Blanco; Bin Li; Jun Long; Chen Shen; Fan Yang; Darren Orton; Sara Collins; Noriyuki Kasahara; Nagi G Ayad; Heather J McCrea; Martine F Roussel; William A Weiss; Anthony J Capobianco; David J Robbins
Journal:  Clin Cancer Res       Date:  2018-11-28       Impact factor: 12.531

5.  Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.

Authors:  Aniruddha Chatterjee; Peter A Stockwell; Antonio Ahn; Euan J Rodger; Anna L Leichter; Michael R Eccles
Journal:  Oncotarget       Date:  2017-01-24

6.  EAG2 potassium channel with evolutionarily conserved function as a brain tumor target.

Authors:  Xi Huang; Ye He; Adrian M Dubuc; Rintaro Hashizume; Wei Zhang; Jüri Reimand; Huanghe Yang; Tongfei A Wang; Samantha J Stehbens; Susan Younger; Suzanne Barshow; Sijun Zhu; Michael K Cooper; John Peacock; Vijay Ramaswamy; Livia Garzia; Xiaochong Wu; Marc Remke; Craig M Forester; Charles C Kim; William A Weiss; C David James; Marc A Shuman; Gary D Bader; Sabine Mueller; Michael D Taylor; Yuh Nung Jan; Lily Yeh Jan
Journal:  Nat Neurosci       Date:  2015-08-10       Impact factor: 24.884

7.  The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma.

Authors:  Fabiana Salm; Valeriya Dimitrova; André O von Bueren; Paulina Ćwiek; Hubert Rehrauer; Valentin Djonov; Pascale Anderle; Alexandre Arcaro
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

8.  Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma.

Authors:  Grace Ty Chung; Raymond Wm Lung; Angela By Hui; Kevin Yl Yip; John Ks Woo; Chit Chow; Carol Yk Tong; Sau-Dan Lee; Jessie Wf Yuen; Samantha Wm Lun; Ken Ky Tso; Nathalie Wong; Sai-Wah Tsao; Timothy Tc Yip; Pierre Busson; Hyungtae Kim; Jeong-Sun Seo; Brian O'Sullivan; Fei-Fei Liu; Ka-Fai To; Kwok-Wai Lo
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

9.  TAp73 is a marker of glutamine addiction in medulloblastoma.

Authors:  Maria Victoria Niklison-Chirou; Ida Erngren; Mikael Engskog; Jakob Haglöf; Daniel Picard; Marc Remke; Phelim Hugh Redmond McPolin; Matthew Selby; Daniel Williamson; Steven C Clifford; David Michod; Michalis Hadjiandreou; Torbjörn Arvidsson; Curt Pettersson; Gerry Melino; Silvia Marino
Journal:  Genes Dev       Date:  2017-09-26       Impact factor: 12.890

10.  EBF1 is expressed in pericytes and contributes to pericyte cell commitment.

Authors:  Francesca Pagani; Elisa Tratta; Patrizia Dell'Era; Manuela Cominelli; Pietro Luigi Poliani
Journal:  Histochem Cell Biol       Date:  2021-07-16       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.